item management s discussion and analysis of financial condition and results of operations the following discussion and analysis should be read in conjunction with the consolidated financial statements  including the notes thereto  appearing elsewhere in this annual report on form k 
except for the historical information contained herein  the matters discussed in this annual report contain forward looking statements within the meaning of section a of the securities act of  as amended  and section e of the securities exchange act of  as amended  that are based on management s beliefs and assumptions  current expectations  estimates  and projections 
statements that are not historical facts  including without limitation statements which are preceded by  followed by or include the words believes  anticipates  plans  expects  may  should or similar expressions are forward looking statements 
these statements are subject to risks and uncertainties  certain of which are beyond the company s control  and  therefore  actual results may differ materially important factors that may affect future results include  but are not limited to the company s ability to implement more sophisticated operating systems and inventory management programs  the impact of competitive products and pricing  the impact of new fda dietary supplement regulations on the company s products and marketing plans  including  without limitation  product labeling  product names and product structure function claims  dependence on individual products  dependence on individual customers  market and industry conditions including pricing  demand for products  level of trade inventories and raw materials availability and pricing  the success of product development and new product introductions into the marketplace  changes in laws and regulations  the company s ability to identify  recruit and integrate key management personnel  including the cost and timing thereof  litigation and government regulatory action  uncertainty of market acceptance of new products  results of management s evaluation of its business operations and strategies  and other factors discussed under factors affecting future performance in item of this annual report 
the company disclaims any obligation to update any forward looking statements whether as a result of new information  future events or otherwise 
overview the company develops  manufactures  markets  distributes and sells branded and private label vitamins  nutritional supplements and sports nutrition products in the united states and throughout the world 
net income loss for the fiscal years ended may   and amounted to million  million and million  respectively 
the company s operating results for fiscal and were affected by several strategic initiatives that were initially and or primarily implemented during this two year period 
these initiatives included  among others  organizational changes and upgrading management systems including senior management changes  the decision to reduce domestic skus by over two thirds  the refinement of the company s growth and business strategies designed to focus on its primary brands and customers  including the introduction of an enhanced marketing plan resulting in significantly increased selling and marketing costs  the expansion of the company s international operations primarily from the acquisition of haleko  the closing of the company s capsule and tablet manufacturing facility in california  the limitation of contract manufacturing private label business to select customers that otherwise carry the company s brands and certain other initiatives 
the implementation of these initiatives and the refinement of the company s growth and business strategies is an ongoing process 
while the focus of this process is to improve future profitability  no assurance can be given that decisions made by the company relating to these initiatives will not adversely effect the company s financial condition and results of operations 
the company experienced growth in sales over the past three fiscal years 
net sales were million  million and million for fiscal years  and  respectively 
the company s growth has been a result of the company s acquisition strategy  increased demand for the company s products  including the growth in schiff r pain free tm move free tm sales and the company s increased penetration of the mass market distribution channel 
in july  the company acquired of the outstanding shares of haleko hanseatisches lebensmittle kontor gmbh  haleko  which is the largest sports nutrition company in europe and is headquartered in germany 
the company s acquisition of haleko resulted in incremental net sales of approximately million and million ten months in fiscal and  respectively 
haleko had sales of approximately million for the twelve months ending may the following table shows selected items as reported and as a percentage of net sales for the years indicated dollars in thousands net sales    cost of goods sold    gross profit    operating expenses    severance  recruiting and reorganizational costs   
management and employee compensation charges 


plant consolidation and transition  other inventory related charges  asset impairment costs 
total operating expenses    income loss from operations    other expense  net    income tax expense benefit  
  net income loss  
  results of operations fiscal compared to fiscal net sales 
net sales for the fiscal year ended may  increased million  or  to million from million for the fiscal year ended may  the following table shows comparative net sales results categorized by distribution channel as reported and as a percentage of net sales for the fiscal years indicated dollars in thousands mass market   health food stores   health clubs and gyms   international markets   contract manufacturing 
 other   total   sales to mass market customers including food  drug  mass  club and convenience stores increased approximately to million in fiscal from million in fiscal the increase in sales to mass market customers was primarily the result of increased sales to existing accounts of certain leading branded products  including schiff r pain free tm move free tm  offset by reduced volumes of certain other branded products primarily due to the company s sku reduction program and a temporary delay in the introduction of new products primarily during the first nine months of fiscal 
gross sales of the company s schiff r pain free tm move free tm products amounted to million for fiscal compared to million for fiscal sales to health food stores decreased approximately to million for fiscal from million for fiscal sales to health clubs and gyms decreased approximately to million for fiscal from million for fiscal the decrease in sales resulted primarily from the company s increased focus on the mass market distribution channel as well as a temporary delay in the introduction of new products into the health food  and health club and gym distribution channels 
gross sales of new products  including line extensions  amounted to approximately million for fiscal compared to approximately million for fiscal sales to international markets increased to million for the year ended may  from million for the year ended may  the increase in sales to international markets resulted primarily from the company s acquisition of haleko in july and the growth in haleko s sportswear business 
haleko s net sales amounted to million and million  respectively  for the years ended may  and may  the company s financial results for fiscal included haleko s operating results for an entire year compared to ten months included in fiscal 
contract manufacturing private label sales volume decreased approximately to million for fiscal from million for fiscal the decrease in contract manufacturing sales is consistent with the company s decision to limit contract manufacturing business to select customers that otherwise carry the company s brands 
private label business for customers that otherwise carry the company s brands are included in the net sales amounts for the distribution channel applicable to such customer 
the company s three largest customers accounted for approximately of the company s aggregate net sales for the year ended may  and for the year ended may  gross profit 
gross profit increased approximately to million for the year ended may  from million for the year ended may  gross profit  as a percentage of net sales  was for the year ended may  compared to for the year ended may  the increase in the gross profit percentage resulted primarily from a change in domestic sales mix  efficiencies from consolidation of the company s capsule and tablet manufacturing facilities  increased higher margin international sales  and reduced credits for returned products and decreased inventory related costs 
operating expenses 
operating expenses  including certain severance  recruiting and reorganization costs  increased approximately to million for fiscal from million for fiscal during fiscal the company continued its initiative for organizational changes and upgrading of management systems including senior management changes that resulted in approximately million of costs incurred during the year 
during fiscal the company recognized  in aggregate  approximately million in charges relating to the consolidation of capsule and tablet manufacturing to its utah facility  severance costs related to the departure of a former ceo and the termination of approximately twenty employees and other inventory charges resulting from charitable contributions and excess labels  packaging and discontinuation of certain skus to comply with dshea product labeling requirements effective march excluding these charges for the respective periods  operating expenses increased million  or during fiscal in comparison to fiscal primarily due to increased selling and marketing expenses 
selling and marketing expenses  including sales  marketing  advertising  freight and other costs  increased approximately to million for fiscal from million for fiscal the increase in selling and marketing expenses resulted primarily from the acquisition of haleko  increased advertising and promotion costs associated with the company s brand building initiatives and personnel costs required to handle higher sales volumes 
the company expects its selling and marketing expenses  as a percentage of sales  to increase in future years 
general and administrative expenses increased approximately to million for the year ended may  compared to million for the year ended may  the increase in general and administrative expenses for fiscal resulted primarily from the acquisition of haleko and increased employee compensation and other personnel costs  partially offset by a reduction in legal costs 
other expense 
other expense  net  amounted to million for the year ended may  compared to million for the year ended may  the net increase of approximately million resulted primarily from increased fees and interest costs associated with extending the maturity date of the previous credit facility  together with an overall higher effective borrowing rate 
income taxes 
provision for income taxes amounted to million for the year ended may  compared to a tax benefit of million for the year ended may  the income tax expense resulted primarily from realization of pre tax earnings for fiscal in comparison to a pre tax loss for fiscal effective tax rate changes result primarily from tax rate differences for the company s domestic and international operations 
results of operations fiscal compared to fiscal net sales 
net sales for the year ended may  increased million  or  to million from million for the year ended may the following table shows comparative net sales results categorized by distribution channel as reported and as a percentage of net sales for the fiscal years indicated dollars in thousands mass market   health food stores   health clubs and gyms   international markets   contract manufacturing   other   total   sales to mass market customers and international markets increased during compared to sales to mass market customers increased approximately to million in from million in the increase in sales to mass market customers resulted primarily from increased penetration of the market and the sale of new products offset by the effects of the company s fiscal strategic initiatives 
gross sales of schiff r pain free tm move free tm amounted to approximately million for the year ended may  compared to million for the year ended may  sales to international markets increased million to million for the year ended may  from million for the year ended may  the increase in sales to international markets resulted primarily from the company s acquisition of haleko offset by a relatively small decrease in other international sales volume resulting primarily from a change in year end for international operations 
haleko s sales for fiscal ten months amounted to approximately million 
overall sales to health food stores decreased approximately to million for fiscal compared to million for fiscal the decrease in sales resulted primarily from the company s increased focus on the mass market distribution channel together with certain individual retailers in the health food distribution channel 
sales to gnc  the company s most significant health food retailer  remained relatively constant in fiscal compared to fiscal  whereas sales to other health food stores decreased in fiscal compared to fiscal sales to health clubs and gyms decreased approximately to million for fiscal from million for fiscal the decrease resulted primarily from reduced volumes with certain distributors 
contract manufacturing private label sales volume decreased approximately to million for the year ended may  from million for the year ended may  the decrease in contract manufacturing sales is consistent with the company s decision to limit contract manufacturing business to select customers that otherwise carry the company s brands 
the company s three largest customers accounted for approximately of net sales for the year ended may  and for the year ended may  gross profit 
gross profit increased approximately to million for the year may  from million for the year ended may  gross profit  as a percentage of net sales  was for the year ended may  compared to for the year ended may  the decrease in the gross profit percentage resulted primarily from inventory charges recognized due to the company s domestic sku reduction program together with associated credits for returned goods 
operating expenses 
operating expenses increased approximately to million for the year ended may  from million for the year ended may  as discussed previously  the company initiated several strategic decisions during fiscal  including  among others  the closing of its california based capsule and tablet manufacturing facility  the implementation of a domestic sku reduction program  organizational changes and upgrading management systems  and the expansion of the company s international operations 
these initiatives  together with the acquisition of haleko  general sales growth and increased legal costs  resulted in a significant increase in total operating expenses 
selling and marketing expenses increased approximately to million for the year ended may  from million for the year ended may  selling and marketing expenses as a percentage of net sales were for the year ended may  compared to for the year ended may  the increase in selling and marketing expense resulted primarily from the company s acquisition of haleko and incremental advertising and promotional costs in support of the company s brand building strategies 
total selling  marketing and advertising costs amounted to million in fiscal compared to million in fiscal incremental selling and marketing costs resulting from the haleko acquisition amounted to million in fiscal general and administrative expenses  as a percentage of net sales  were for the year ended may  compared to for the year ended may  the increase resulted primarily from increased legal costs  year implementation and compliance costs  as well as other costs associated with information system capabilities and the incremental costs associated with the acquisition of haleko 
other expense 
other expense  net  amounted to million for the year ended may  compared to million for the year ended may  the net increase of approximately million consists primarily of increased interest costs associated with additional indebtedness incurred in connection with the acquisition of haleko as well as a higher overall effective borrowing rate for fiscal in comparison to fiscal income taxes 
the company recognized an income tax benefit for the fiscal year ended may  as a result of its pretax loss 
the company s overall effective tax rate is higher in fiscal  in comparison to  primarily as a result of a higher effective tax rate associated with haleko s operating results 
income taxes benefit  as a percentage of pre tax income  amounted to approximately for the year ended may  compared to for the year ended may  liquidity and capital resources effective june   the company and its domestic subsidiaries entered into a new million senior credit facility the new credit facility with bankers trust company 
the new credit facility replaced the company s previous credit facility  which consisted of a revolving line of credit that expired on june  the new credit facility is comprised of a million term loan and a million revolving loan 
under the revolving loan  the company may borrow up to the lesser of million or the sum of i of eligible accounts receivable and ii the lesser of million or of the eligible inventory 
the new credit facility contains customary terms and conditions  including  among others  financial covenants regarding minimum cash flows and limitations on indebtedness and the company s ability to pay dividends under certain circumstances 
the obligations of the company under the new credit facility are secured by a first priority lien on all owned or acquired tangible and intangible assets of the company and its domestic subsidiaries 
the new credit facility is being used to fund the normal working capital and capital expenditure requirements of the company 
at the inception of the new credit facility  the company borrowed approximately million together with the proceeds from the subordinated loan discussed below to repay in full its outstanding obligation under the previous credit facility and related financing costs of the new credit facility 
concurrently with the new credit facility  on june  the company entered into a million senior subordinated loan agreement the subordinated loan 
the proceeds from the subordinated loan were used to repay outstanding obligations under the company s previous credit facility 
the subordinated loan contains customary terms and conditions  including  among others  financial covenants regarding minimum cash flows and limitations on indebtedness and the company s ability to pay dividends under certain circumstances 
the company had working capital of approximately million at may  compared to million at may  excluding million outstanding at may  under the previous credit agreement  see note to the consolidated financial statements 
the decrease in working capital resulted primarily from reduced receivables and inventories 
current receivables and inventories decreased million and million  respectively  during the year ended may  the decrease in receivables was primarily attributable to a change in customer sales mix 
the decrease in inventories was primarily attributable to improved inventory management  including the company s sku reduction program 
during fiscal  the company s aggregate current and long term debt decreased approximately million to million at may   primarily as a result of the decrease in receivables and inventories 
the company expects to fund its long term capital requirements for the next twelve months through the use of operating cash flow supplemented as necessary by borrowings under both the new credit agreement and haleko s approximate million secured credit facility see note to the consolidated financial statements 
the company also from time to time may evaluate strategic acquisitions as the nutritional supplements industry continues to consolidate 
the funding of future acquisitions  if any  may require other debt financing or the issuance of additional equity 
the company paid an annual dividend of per share quarterly dividend of per share for fiscal in addition  the company paid a quarterly dividend of per share subsequent to year end 
the dividend was declared to be payable on june  to holders of all classes of common stock of record at the close of business on june  the company s board of directors will determine dividend policy in the future based upon  among other things  the company s results of operations  financial condition  contractual restrictions and other factors deemed relevant at the time 
in addition  the new credit agreement contains certain customary financial covenants that may limit the company s ability to pay dividends on its common stock 
accordingly  there can be no assurance that the company will be able to sustain the payment of dividends in the future 
impact of inflation the company has historically been able to pass inflationary increases for raw materials and other costs onto its customers through price increases and anticipates that it will be able to continue to do so in the future 
seasonality the company s business is seasonal  with lower sales typically realized during the first and second fiscal quarters and higher sales typically realized during the third and fourth fiscal quarters 
the company believes such fluctuations in sales are the result of greater marketing and promotional activities toward the end of each fiscal year  customer buying patterns  and consumer spending patterns related primarily to the consumers interest in achieving personal health and fitness goals after the beginning of each new calendar year and before the summer fashion season 
furthermore  as a result of changes in product sales mix and other factors  as discussed above  the company experiences fluctuations in gross profit and operating margins on a quarter to quarter basis 
recently issued accounting standards in june  the fasb issued sfas no 
 accounting for derivative instruments and hedging activities  which supersedes sfas no 
 accounting for futures contracts  sfas no 
 disclosure of information about financial instruments with off balance sheet risk and financial instruments with concentration of credit risk  and sfas no 
 disclosures about derivative financial instruments and fair value of financial instruments  and also amends certain aspects of other sfas s previously issued 
sfas no 
establishes accounting and reporting standards for derivative instruments and hedging activities 
it requires that an entity recognize all derivatives as either assets or liabilities in the balance sheet and measure those instruments at fair value 
sfas no 
 as amended by sfas no 
 is effective for the company s financial statements for the year ending may  the company does not expect the impact of adopting sfas no 
to be material in relation to its financial statements 
in december  the securities and exchange commission issued staff accounting bulletin sab  revenue recognition in financial statements 
sab establishes accounting and reporting standards for the recognition of revenue 
it states that revenue generally is realized or realizable and earned when all of the following criteria are met persuasive evidence of an arrangement exists  delivery has occurred or services have been rendered  the seller s price to the buyer is fixed or determinable  and collectibility is reasonably assured 
sab is effective for the company s financial statements in the fiscal quarter beginning march  the company has not determined the impact of adopting sab to the company s financial statements 
year as of august   the company is not aware of any material year problems in any of its critical systems and services 
in addition  the company has not received any notification from any supplier of critical systems or services of any material year related problems in their businesses 
in the event that any year related problems arise in the future  the company formulated a year plan to address such issues 
however  although the company has a year plan  no assurance can be given that such plan will be able to solve all year issues that might still arise or that the failure to solve any such year issue will not have a material adverse effect on the company 
item a 
quantitative and qualitative disclosures about market risk the following discussion involves forward looking statements of market risk which assume for analytical purposes that certain adverse market conditions may occur 
actual future market conditions may differ materially from such assumptions 
accordingly  the forward looking statements should not be considered projections by the company of future events or losses 
the company s cash flows and net earnings are subject to fluctuations resulting from changes in interest rates and foreign exchange rates 
the company currently is not party to any significant derivative instruments and its current policy does not allow speculation in derivative instruments for profit or execution of derivative instrument contracts for which there are no underlying exposure 
the company does not use financial instruments for trading purposes 
the company measures its market risk  related to its holdings of financial instruments  based on changes in interest rates utilizing a sensitivity analysis 
the company does not believe that a hypothetical change in interest rates would nave a material effect on the company s pretax earnings or cash flows 

